Some studies have shown that inhibition of EGFR in different AD animal models leads to antiamyloidogenic and autophagy enhancement effects [43–45], anti-neuroinflammatory, antioxidant, and anti-astrogliosis effects [44, 46]. The gene discussed is EGFR; the disease is Alzheimer disease.